4//SEC Filing
Okey Stephanie 4
Accession 0001209191-24-005184
CIK 0001658247other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:35 PM ET
Size
9.1 KB
Accession
0001209191-24-005184
Insider Transaction Report
Form 4
Okey Stephanie
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-28$18.29/sh+17,500$320,075→ 23,500 total - Sale
Common Stock
2024-03-28$46.38/sh−17,500$811,650→ 6,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-03-28+17,500→ 0 totalExercise: $18.29Exp: 2032-06-17→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $46.38 per share. The range of sales prices on the transaction date was $46.06 to $46.66 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F2]The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001742616
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:35 PM ET
- Size
- 9.1 KB